Model Medicines

📍 La Jolla, United States🗓 Founded 2019👥 16 employees💰 Last funded May 2024
Biotechnology Research🌐 modelmedicines.com
Website LinkedIn
Model Medicines is an AI-driven, human health company using AI to model all of chemistry and human biology, to accelerate the creation of life-changing drugs. The company was founded in 2019 to deliver on the promise of AI-Drug discovery. With more than 182 compounds for 26 targets, they are delivering on the promise of AI-drug discovery. The company has developed a robust pipeline of patent-pending therapeutics for oncology, infectious diseases, gastric disorders, neurological disorders, and weight disorders. The company is based in La Jolla, CA.
4
Total investors
2
Early stage
2
Mid stage
0
Late stage
2019
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2020–2024 · investors recorded per year
20201202112022120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Model Medicines?
Model Medicines has 4 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage.
When did Model Medicines last raise funding?
The most recent investment in Model Medicines recorded on gritt.io was in May 2024.
When was Model Medicines founded?
Model Medicines was founded in 2019.
What industry is Model Medicines in?
Model Medicines operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Model Medicines based?
Model Medicines is headquartered in La Jolla, United States.